EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection

Auriane Maïza iD, Rifat Hamoudi iD, Aloïse Mabondzo iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105449 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Auriane Maïza und 2 weiteren Autor:innen. Beteiligte Einrichtung: CEA, DMTS, SPI, Neurovascular Unit Research & Therapeutic Innovation Laboratory, Paris-Saclay University, CEDEX 91191 Gif-sur-Yvette, France. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Neuroprotection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIH, ANR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxic-ischemic encephalopathy (HIE) is a major cause of newborn brain damage stemming from a lack of oxygenated blood flow in the neonatal period. Twenty-five to fifty percent of asphyxiated infants who develop HIE die in the neonatal period, and about sixty percent of survivors develop long-term neurological disabilities. From the first minutes to months after the injury, a cascade of events occurs, leading to blood-brain barrier (BBB) opening, neuronal death and inflammation. To date, the only approach proposed in some cases is therapeutic hypothermia (TH). Unfortunately, TH is only partially protective and is not applicable to all neonates. This review synthesizes current knowledge on the basic molecular mechanisms of brain damage in hypoxia-ischemia (HI) and on the different therapeutic strategies in HI that have been used and explores a major limitation of unsuccessful therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Ischemia, BrainNeuroprotectionAnimalsHumansInfant, NewbornBlood-Brain BarrierHypothermia, InducedNeuroprotective AgentsAnimals, Newborn

Stichwörter der Autor:innen

blood-brain barrierhypoxia-ischemiainflammationneuroprotectiontherapy

Substanzen

Neuroprotective Agents

Autor:innen und Institutionen

  • CEA, DMTS, SPI, Neurovascular Unit Research & Therapeutic Innovation Laboratory, Paris-Saclay University, CEDEX 91191 Gif-sur-Yvette, France.
  • Center of Excellence of Precision Medicine, Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.
  • College of Medicine, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.
  • Division of Surgery and Interventional Science, University College London, London NW3 2PF, UK.

ORCID-Profile: Auriane Maïza, Rifat Hamoudi, Aloïse Mabondzo

Förderung

  • NIH HHS
  • NIH
  • ANR
  • Biorender

Zitieren

APA

Maïza, A., Hamoudi, R., & Mabondzo, A. (2024). Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105449

Vancouver

Maïza A, Hamoudi R, Mabondzo A. Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105449

BibTeX
@article{Maza2024,
  author = {Maïza, Auriane and Hamoudi, Rifat and Mabondzo, Aloïse},
  title = {Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105449}
}
Kostenlos starten →